Cargando…

Gallbladder Cancer With Jaundice: Surgery Versus No Surgery

Background Patients with gallbladder carcinoma (GBC) and jaundice have a poor prognosis. The surgical management of these patients is controversial. There is a dearth of studies comparing curative surgical resection (CR) versus non-curative resection/palliation (NCR) in patients with GBC and jaundic...

Descripción completa

Detalles Bibliográficos
Autores principales: K, Sugumaran, Jajal, Vasistha M, Nekarakanti, Phani K, Choudhary, Devendra, Nag, Hirdaya H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679131/
https://www.ncbi.nlm.nih.gov/pubmed/36420237
http://dx.doi.org/10.7759/cureus.30594
_version_ 1784834126389444608
author K, Sugumaran
Jajal, Vasistha M
Nekarakanti, Phani K
Choudhary, Devendra
Nag, Hirdaya H
author_facet K, Sugumaran
Jajal, Vasistha M
Nekarakanti, Phani K
Choudhary, Devendra
Nag, Hirdaya H
author_sort K, Sugumaran
collection PubMed
description Background Patients with gallbladder carcinoma (GBC) and jaundice have a poor prognosis. The surgical management of these patients is controversial. There is a dearth of studies comparing curative surgical resection (CR) versus non-curative resection/palliation (NCR) in patients with GBC and jaundice. Hence, this study aimed to compare the outcomes between CR and NCR in these patients. Methodology This was a retrospective study on patients with GBC and jaundice managed by a single surgical unit at a tertiary care center in northern India from May 2009 to March 2021. These patients were grouped into CR or NCR. The clinical demographical profile and overall survival (OS) were compared between the groups. Results A total of 82 patients with GBC and jaundice were managed during the study period. The final study cohort included 59 patients (CR, n = 34; NCR, n = 25) after excluding patients with metastatic disease (n = 23). Common bile duct infiltration was seen in 61.7% and 84% of CR and NCR patients, respectively (p = 0.062). The overall tumor-node-metastasis staging between the two groups was similar (p = 0.296). The median OS of CR was significantly better in CR than NCR (20 months vs. six months; p = 0.001). The median OS was better in CR than NCR patients who received systemic chemotherapy (22 vs. 12 months; p = 0.001) or did not receive chemotherapy (14 months vs. three months; p = 0.001). Conclusions Patients with GBC and jaundice have better significant survival after CR than NCR alone.
format Online
Article
Text
id pubmed-9679131
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-96791312022-11-22 Gallbladder Cancer With Jaundice: Surgery Versus No Surgery K, Sugumaran Jajal, Vasistha M Nekarakanti, Phani K Choudhary, Devendra Nag, Hirdaya H Cureus Gastroenterology Background Patients with gallbladder carcinoma (GBC) and jaundice have a poor prognosis. The surgical management of these patients is controversial. There is a dearth of studies comparing curative surgical resection (CR) versus non-curative resection/palliation (NCR) in patients with GBC and jaundice. Hence, this study aimed to compare the outcomes between CR and NCR in these patients. Methodology This was a retrospective study on patients with GBC and jaundice managed by a single surgical unit at a tertiary care center in northern India from May 2009 to March 2021. These patients were grouped into CR or NCR. The clinical demographical profile and overall survival (OS) were compared between the groups. Results A total of 82 patients with GBC and jaundice were managed during the study period. The final study cohort included 59 patients (CR, n = 34; NCR, n = 25) after excluding patients with metastatic disease (n = 23). Common bile duct infiltration was seen in 61.7% and 84% of CR and NCR patients, respectively (p = 0.062). The overall tumor-node-metastasis staging between the two groups was similar (p = 0.296). The median OS of CR was significantly better in CR than NCR (20 months vs. six months; p = 0.001). The median OS was better in CR than NCR patients who received systemic chemotherapy (22 vs. 12 months; p = 0.001) or did not receive chemotherapy (14 months vs. three months; p = 0.001). Conclusions Patients with GBC and jaundice have better significant survival after CR than NCR alone. Cureus 2022-10-22 /pmc/articles/PMC9679131/ /pubmed/36420237 http://dx.doi.org/10.7759/cureus.30594 Text en Copyright © 2022, K et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Gastroenterology
K, Sugumaran
Jajal, Vasistha M
Nekarakanti, Phani K
Choudhary, Devendra
Nag, Hirdaya H
Gallbladder Cancer With Jaundice: Surgery Versus No Surgery
title Gallbladder Cancer With Jaundice: Surgery Versus No Surgery
title_full Gallbladder Cancer With Jaundice: Surgery Versus No Surgery
title_fullStr Gallbladder Cancer With Jaundice: Surgery Versus No Surgery
title_full_unstemmed Gallbladder Cancer With Jaundice: Surgery Versus No Surgery
title_short Gallbladder Cancer With Jaundice: Surgery Versus No Surgery
title_sort gallbladder cancer with jaundice: surgery versus no surgery
topic Gastroenterology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679131/
https://www.ncbi.nlm.nih.gov/pubmed/36420237
http://dx.doi.org/10.7759/cureus.30594
work_keys_str_mv AT ksugumaran gallbladdercancerwithjaundicesurgeryversusnosurgery
AT jajalvasistham gallbladdercancerwithjaundicesurgeryversusnosurgery
AT nekarakantiphanik gallbladdercancerwithjaundicesurgeryversusnosurgery
AT choudharydevendra gallbladdercancerwithjaundicesurgeryversusnosurgery
AT naghirdayah gallbladdercancerwithjaundicesurgeryversusnosurgery